Olema Historical Cash Flow
| OLMA Stock | USD 10.12 0.40 4.12% |
Analysis of Olema Pharmaceuticals cash flow over time is an excellent tool to project Olema Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Net Borrowings of 2.4 M or Stock Based Compensation of 10.1 M as it is a great indicator of Olema Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Olema Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Olema Pharmaceuticals is a good buy for the upcoming year.
Olema |
About Olema Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Olema balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Olema's non-liquid assets can be easily converted into cash.
Olema Pharmaceuticals Cash Flow Chart
Add Fundamental
Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Olema Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Olema Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Olema Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Olema Stock refer to our How to Trade Olema Stock guide.At present, Olema Pharmaceuticals' Sale Purchase Of Stock is projected to increase significantly based on the last few years of reporting. The current year's Investments is expected to grow to about 44.5 M, whereas Stock Based Compensation is forecasted to decline to about 10.1 M.
Olema Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Olema Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Olema Pharmaceuticals cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (3.1M) | 338.5M | (324.7M) | 9.9M | 44.8M | 47.1M | |
| Stock Based Compensation | 0.0 | 3.1M | 15.9M | 18.8M | 17.3M | 10.1M | |
| Free Cash Flow | (3.1M) | (19.9M) | (52.3M) | (82.4M) | (83.7M) | (79.5M) | |
| Change In Working Capital | 1.2M | (1.5M) | 2.8M | 3.0M | (589K) | (559.6K) | |
| Begin Period Cash Flow | 3.1M | 68K | 338.5M | 13.8M | 23.7M | 22.5M | |
| Depreciation | 9K | 11K | 163K | 357K | 377K | 395.9K | |
| Other Non Cash Items | (1.1M) | 641K | 1.2M | 514K | (4.1M) | (3.9M) | |
| Total Cash From Operating Activities | (3.1M) | (19.9M) | (50.7M) | (82.1M) | (83.7M) | (79.5M) | |
| Change To Operating Activities | 416K | (1.3M) | 3.5M | 2.7M | 3.1M | 3.2M | |
| Net Income | (4.3M) | (22.1M) | (71.1M) | (104.8M) | (96.7M) | (91.8M) | |
| End Period Cash Flow | 68K | 338.5M | 13.8M | 23.7M | 68.5M | 82.1M | |
| Change To Liabilities | 810K | (220K) | (683K) | 7.4M | 8.5M | 8.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Olema Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Olema Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Olema Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Olema Pharmaceuticals Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Olema Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Olema Stock refer to our How to Trade Olema Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Olema Pharmaceuticals. If investors know Olema will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Olema Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.28) | Return On Assets (0.32) | Return On Equity (0.52) |
The market value of Olema Pharmaceuticals is measured differently than its book value, which is the value of Olema that is recorded on the company's balance sheet. Investors also form their own opinion of Olema Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Olema Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Olema Pharmaceuticals' market value can be influenced by many factors that don't directly affect Olema Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Olema Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Olema Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Olema Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.